New - European Medical Journal

Continue

News

Hepatology
21 Nov 2016

Liver Fibrosis Limited by Insulin-Like Growth Factor-I

FIBROSIS of the liver has been found to be limited by insulin-like growth factor-I (IGF-I), typically induced by growth hormones, according to a study by…
EMJ
Hepatology
21 Nov 2016

Energy Drinks Associated with Hepatitis

ENERGY DRINKS have been associated with liver damage in a new case report authored by Dr Jennifer Harb, Department of Dermatology, University of…
Respiratory
17 Nov 2016

EAACI Sheds Light on Recent Developments in Severe Asthma

United Kingdom, November 17, 2016 – The European Academy of Allergy and Clinical Immunology (EAACI) hosts today in Manchester the 3rd International…
Oncology
15 Nov 2016

Introducing EMJ Dermatology 4.1

United Kingdom, November 15, 2016: Hello and welcome to this year’s EMJ Dermatology eJournal, updating the field with cutting-edge developments within…
Oncology
14 Nov 2016

Pancreatic Cancer Set to Become Third Biggest Cancer Killer in EU next Year

Vienna, November 7, 2016 – The number of deaths from pancreatic cancer will overtake breast cancer mortality rates in the EU in 2017, a study has found.1
EMJ
Diabetes
14 Nov 2016

Novel Signalling Cascade Blockade May Be the Answer to Type 1 Diabetes Prevention

PREVENTION of Type 1 diabetes mellitus (T1DM) development in patients may now be a possibility, according to a paper published by Dr Carolin Daniel and…
EMJ
Diabetes
14 Nov 2016

Do Artificially-Sweetened Drinks Still Increase the Risk of Diabetes?

DIABETES development, particularly Type 2 diabetes mellitus (T2DM), has previously been shown to correlate with sugary drink intake, however a new study…
Respiratory
14 Nov 2016

New App Harnesses Gamification for Smoking Cessation

United Kingdom, November 14, 2016 – A framework to gamify anti-smoking apps, and potentially improve adherence to non-smoking regimens, has been…